Cathy Burgess comments on final guidance by the U.S. Food and Drug Administration for companies involved in contract drug manufacturing.
In the News
November 28, 2016
Bloomberg BNA | FDA Issues Guidance for Quality Contracts Between Drugmakers
Media Contact